/Companies

Esphera SynBio Inc.

Toronto, CA · 3 known investors

Find your way into Esphera SynBio Inc.

Sign up to see every warm intro you have to Esphera SynBio Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Esphera SynBio Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Esphera designs transgenes that enable budding exosomes to carry multimeric proteins for therapeutic applications, with initial focus on modifying tumor-derived exosomes to create immunostimulatory cancer vaccines.

Founders & leadership

BLBrian Lichty
Brian LichtyFounder, CEO
CICarolina Ilkow
Carolina IlkowFounder, CSO
JBJohn Bell
John BellFounder, President

Investors · 3

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Esphera SynBio Inc. do?
Esphera designs transgenes that enable budding exosomes to carry multimeric proteins for therapeutic applications, with initial focus on modifying tumor-derived exosomes to create immunostimulatory cancer vaccines.
Who founded Esphera SynBio Inc.?
Esphera SynBio Inc. was founded by Brian Lichty, Carolina Ilkow, John Bell.
Who are Esphera SynBio Inc.'s investors?
Esphera SynBio Inc.'s investors include FACIT (Fight Against Cancer Innovation Trust), Ontario Centre of Innovation, Ontario Centre of Innovation programs.
Where is Esphera SynBio Inc. headquartered?
Esphera SynBio Inc. is headquartered in Toronto, CA.